Cerus Endovascular today announced the appointment of Stephen Griffin to chief executive officer, effective immediately. Griffin has been with the company since 2014 and has served as president since 2018. He played a critical role in assembling the current Fremont, California-based company's team and helped establish the Contour brand … [Read more...] about Cerus Endovascular names Stephen Griffin as CEO
Cerus Endovascular
FDA clears Cerus Endovascular 027 microcatheters
Cerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters. Fremont, California-based Cerus Endocascular's new microcatheters are available in two lengths. The company expects to submit for CE mark approval under the EU new Medical Devices Regulation later this year. A limited market release of the 027 … [Read more...] about FDA clears Cerus Endovascular 027 microcatheters
FDA grants IDE approval for Cerus Endovascular’s Contour Neurovascular System clinical study
Cerus Endovascular announced today that it received FDA investigational device exemption for a trial for its Contour Neurovascular System. Fremont, Calif.-based Cerus’ Contour Neurovascular System is designed to treat intracranial aneurysms. It is made of fine mesh braid to target the neck of the aneurysm away from the vulnerable dome. Get the … [Read more...] about FDA grants IDE approval for Cerus Endovascular’s Contour Neurovascular System clinical study
Cerus Endovascular wins CE mark for microcatheter
Cerus Endovascular today said it received CE mark approval for its CerusEndo MC 021 microcatheter. The microcatheter is designed to allow physicians to access torturous neurovasculature and deliver therapeutic device to intended targets. "We remain committed to meeting the ever-increasing needs of the interventional neuroradiologist … [Read more...] about Cerus Endovascular wins CE mark for microcatheter
